MERSANA THERAPEUTICS INC (MRSN)

US59045L1061 - Common Stock

2.58  +0.01 (+0.39%)

After market: 2.58 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
38.30M36.85M26.58M40.00K830.00K
Operating Expenses
172.47M207.81M230.35M168.90M88.94M
Research and Development
119.68M148.27M173.39M132.01M67.04M
Selling, General, and Administrative Expenses
52.77M59.54M56.96M36.89M21.90M
Operating Income
-134.16M-170.96M-203.77M-168.86M-88.11M
Interest Income/Expense
8.06M8.00M-450.00K-1.20M70.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/A-8.71MN/AN/AN/A
Income Before Taxes
-134.82M-171.67M-204.21M-170.06M-88.05M
Net Income
-134.82M-171.67M-204.21M-170.06M-88.05M
EBITDA
-132.54M-169.44M-202.84M-168.00M-87.10M
 
Per Share Data
EPS Diluted Total Ops
-1.14-1.48-2.18-2.41-1.43
Non GAAP EPS
-1.06-1.42-2.19-2.40-1.43
 
Statistics
Profit Margin
-352.05%-465.80%-768.28%-425150.00%-10608.43%
Operating Profit Margin
-350.32%-463.86%-766.63%-422150.00%-10615.66%

All data in USD

Charts